Precision Medicine Market By Technology (Companion diagnostics, Big data analytics, Drug discovery, Bioinformatics, Gene sequencing and Other Technologies) and End User (CNS, Oncology, Immunology, Respiratory and Other Applications) - Global Industry Analysis And Forecast To 2025

Industry Outlook

The precision medicine (PM) is the medicinal model that includes the customization of the healthcare sector, with the therapeutic choices, medications, practices, or items being custom-made to the patient in individual. In the model, the diagnostic testing is regularly utilized for choosing proper and ideal treatments dependent on the setting of a patient's hereditary content or the cellular analysis or other molecular. Devices utilized in the PM may incorporate the molecular diagnostics, analytics, and imaging. The PM frequently includes the use of systems biology and panomic analysis to break down the reason for an patient's individual ailment at the molecular level and afterward to use the targeted treatments (perhaps in blend) to label that patient's individual ailment procedure. Therefore, the Precision Medicine Market is anticipated to expand and has tremendous scope during the forecast period. The global Precision Medicine Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

On the basis of Technology the market is further divided into Companion diagnostics, Big data analytics, Drug discovery, Bioinformatics, Gene sequencing and Other Technologies. The Drug discovery section is leading the market owing to the development in the field of pharmacogenomics that permits to predict the results of the medicines with the genetic data.

On the basis of End User the market is further divided into CNS, Oncology, Immunology, Respiratory and Other Applications. The Oncology section is leading the market share owing to rise in the number of case relate to cancer, rise in the development of more targeted treatments, etc.

Regional Insights

The North American region is leading the global Precision Medicine Market due to increase in the numbers of cases of cancer, also the regulatory measures that are favorable, various awareness initiatives & campaigns arranged by the public & government organizations, etc.

Precision Medicine Market, By Region




North America


U.S.
Canada
Mexico

Europe


Germany
UK
France
Russia
Italy
Rest of Europe

Asia-Pacific


China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific

South America


Brazil
Argentina
Columbia
Rest of South America

Middle East and Africa


Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA


Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.


Ferrer InCode
Intomics
Quest Diagnostics
F. Hoffmann-La Roche
NanoString Technologies
Silicon Biosystems
Laboratory Corporation of America Holdings
Biocrates Life Sciences
Novartis
Teva Pharmaceutical
Tepnel Pharma Services


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?